Nutrition facts

Serving size
1 Tbsp (6g)
Calories
20
Total fat
.5g
Sodium
10mg
Total carbohydrate
4g
Dietary fiber
1g
Total sugar
0g
Protein
<1g
Potassium
110mg
Iron
0.4mg
Mushrooms
2,240mg
Caffeine
35mg

INGREDIENTS: Organic Mushroom Blend (Chaga, Reishi, Lion's Mane and Cordyceps Mushrooms and Mycelium cultured on Organic Oats and/or Organic Sorghum), Organic Cacao, Organic Spice Blend (Organic Cinnamon, Organic Turmeric, Organic Ginger, Organic Cardamom, Organic Black Pepper, Organic Nutmeg, Organic Cloves), Organic Black Tea Powder, Himalayan Pink Salt

100% USDA Organic, non-gmo, gluten free, vegan, Whole30 & Kosher

Nutrition facts

Serving size
1 Tbsp (6g)
Calories
20
Total fat
0g
Sodium
10mg
Total carbohydrate
4g
Dietary fiber
1g
Total sugar
0g
Protein
1g
Iron
2mg
Mushrooms
3,000mg
Caffeine
55mg

INGREDIENTS: Organic Mushroom Blend (Chaga, Reishi, Lion's Mane and Cordyceps mushrooms and mycelium cultured on organic oats and/or organic sorghum), Organic Matcha, Organic Cinnamon, Organic Turmeric, Organic Ginger, Organic Black Pepper, Organic Cardamom, Himalayan Pink Salt

100% USDA Organic, Gluten Free, Vegan, Non-GMO, Kosher, Whole30 Approved

Nutrition facts

Serving size
1 Tbsp (6g)
Calories
20
Total fat
0g
Sodium
10mg
Total carbohydrate
4g
Dietary fiber
1g
Total sugar
0g
Protein
1g
Potassium
60mg
Iron
1.8mg
Mushrooms
1,840mg
Caffeine
0mg

INGREDIENTS: Organic Spice Blend (Organic Turmeric, Organic Cinnamon, Organic Ginger, Organic Cardamom, Organic Black Pepper), Organic Mushroom Blend (Chaga, Reishi, Lion’s Mane and Cordyceps mushrooms and mycelium grown on organic oats and/or organic sorghum), Organic Lucuma Fruit Powder, Organic Baobab Fruit Powder, Organic Rooibos Tea Extract, Himalayan Pink Salt

100% USDA Organic, Vegan, Non-GMO, Kosher, Gluten Free

Nutrition facts

Serving size
1 Tbsp (6g)
Calories
20
Total fat
0g
Sodium
5mg
Total carbohydrate
4g
Dietary fiber
1g
Total sugar
0g
Protein
0g
Iron
0.3mg
Mushrooms
2,240mg
Caffeine
0mg

INGREDIENTS: Organic Mushroom Blend (Turkey Tail and Reishi Mushrooms and Mycelium cultured on Organic Oats and/or Organic Sorghum), Organic Lucuma Fruit Powder, Organic Rooibos Tea Extract, Organic Spice Blend (Organic Turmeric, Organic Cinnamon, Organic Ginger, Organic Cardamom, Organic Black Pepper, Organic Nutmeg, Organic Cloves), Organic Valerian Root Extract, Passionflower Extract, Organic Ashwagandha Root Extract, Organic Chamomile Extract

Organic, kosher, non-GMO, gluten-free and vegan

Nutrition facts

Serving size
1 Tbsp (6g)
Calories
45
Total fat
4.5g
Sodium
0mg
Total carbohydrate
3g
Dietary fiber
0g
Total sugar
0g
Protein
<1g

INGREDIENTS: Organic Coconut Milk Power, Organic MCT Powder (Medium Chain Triglycerides), Organic Acacia Fiber, Organic Tapioca Maltodextrin (Derived from Organic Yuca Root). Contains Coconut.

How it works

What you're getting

In the first month, your subscription box will include:

  • 30 serving tin of your favorite blend
  • Free rechargeable frother
  • Free guidebook
  • Free sample of :creamer
  • Free sample of :sweetener
  • Free sticker

What does it cost

Subscribing is a great way to save money. You’ll save 33% on every box!

Your first Starter Kit box will cost: $40.00 USD (compared to $60.00 USD for non-subscription Starter Kit boxes).

Each subsequent box with a 30-serving tin will cost: $40.00 USD (compared to $50.00 USD per tin)

How to make changes

You can adjust or cancel your subscription at any time! There is no charge to make changes. Visit your subscription management page or email [email protected].

Offer details

The Black Friday/Cyber Monday Sale is active Nov. 20, 2022 through Nov. 28, 2022 and requires an order minimum of $35 to receive 25% off. Code RITUAL25 is site-wide on orders over $35 and auto-applied in most cases. The code can also be entered at checkout.

Additionally, 5% of each order will be donated to The MINDS Foundation throughout the promotion dates. The donation amount will be announced on Instagram (@drinkmudwtr) and via email to participants of the sale no later than Dec. 31, 2022.

Why Subscribe?

Join 100,000+ happy customers
saving $20 off their Starter Kit order

  • Convenient Auto-Delivery

    (Never run out of MUD\WTR again)

  • Pre-Shipment Reminders

    (Edit, Skip, Delay or Swap)

  • No Commitments, Cancel Anytime

Gifting MUD\WTR

Giving the gift of MUD\WTR? We love to see it (they will, too). Here are some things to keep in mind when gifting MUD\WTR.

  • Only on-demand Starter Kits can be gifted (no subscriptions)
  • No mixing subscriptions with on-demand products
  • The gift message applies to the entire cart

Your gift message


  Is This Trip Really Necessary? 
< Back

Is This Trip Really Necessary? 

What happens when you take the “psychedelic” out of psychedelic medicine?

Damon Orion

If you’ve had a deeply healing entheogenic experience, the phrase “psychedelic medicine” probably makes perfect sense to you. If you haven’t, it might sound as absurd to you as “medical crack” or “vodka therapy.”  

However, as the evidence mounts, the masses are swiftly warming up to the concept of entheogenic healing. Study after study is confirming that psychedelic compounds can facilitate dramatic improvement in neuropsychiatric conditions such as depression, anxiety, addiction and PTSD. 

Ironic, isn’t it? Substances that have long been thought to cause brain damage and psychiatric disorders may do just the opposite. Entheogenic psychoplastogens like DMT, ketamine, LSD, psilocybin and MDMA appear to repair the atrophied neurons that have been found in the prefrontal cortices of people with mood disorders and/or compromised cognition

While some people might consider it a bonus that these psychoplastogens make you trip balls, it goes without saying that some would prefer to get their mental and physical healing minus the telepathic conversations with alien mantis beings. Thus, scientists are on the hunt for the entheogenic equivalent of CBD: trip-less psychedelic medicine. 

The Rise of Psych Lite

Along with conducting trials of LSD microdosing as a treatment for Alzheimer’s Disease, the life science company Eleusis has been working to develop trip-less LSD analogs for the treatment of inflammation and of ailments like asthma and arthritis. There’s also a drug development company called Algernon Pharmaceuticals (yes, a curious choice of name), which has been testing the ability of non-hallucinogenic doses of DMT to help repair the brain from the damage of a stroke. These trials build upon prior testing which indicated that DMT can help rats recover from brain injury. 

Some researchers are using a device called psychLight to search for “decaf” psychedelic compounds. PsychLight’s sensor glows when it detects a hallucinogenic compound making changes to a brain cell receptor called Serotonin 5-HT2A. (The hallucinogenic, anti-inflammatory, neuroplastogenic and behavioral properties of psychedelics can all be traced back to their interactions with this receptor.) The use of psychLight has led to the discovery of AAZ-A-154, a non-hallucinogenic psychedelic molecule that shows promise in treating depression. 

In trying to tease apart the treatment from the trip, psychedelic researchers are bumping up against an inescapable question: Does the curative value of these substances come down to neurochemistry, or is the entheogenic experience inseparable from the healing? 

As with most things related to psychedelics, this isn’t a black-and-white issue. Research on 5-MeO-DMT and ayahuasca has revealed a clear connection between improved mental health and the high-intensity mystical experiences that these substances occasioned in study participants. On the other hand, small doses of psilocybin (the “magic” component of magic mushrooms) that don’t produce strong psychedelic effects still appear to be effective in reducing migraines. 

Non-Psychedelic Psilocybin? 

So, if sub-threshold doses of psilocybin can mitigate migraine headaches, can they also help alleviate conditions like depression, anxiety and substance abuse in the same way that larger doses can? 

Perhaps so. When researchers blocked its hallucinogenic effects, lab mice still stopped exhibiting depressive behavior after being treated with psilocybin. Stronger neural connections were still found in the mice’s hippocampi after the compound was administered, as is also the case when non-psychedelic antidepressants are used. 

That study’s lead author told Lucid News, “The tentative conclusion of our study is that the trip is not necessary for the acute antidepressant effect.” She added, though, that the results of a test conducted on mice may not apply where humans are concerned. She also noted that it is not yet known whether the antidepressant effects of psilocybin will be as long-lasting without the psychedelic experience.   

Researchers in Wisconsin are taking psilocybin therapy in a different direction: They’re giving it to sufferers of conditions like depression and anxiety in combination with midazolam, a drug that erases all memory of the trip that the psilocybin brings on. In doing so, they hope to learn whether the therapeutic value of psilocybin is dependent on the lasting memory of a psychedelic experience. 

The Search for an Ibogaine Analog

Derived from the Central African iboga tree, ibogaine is a psychoactive alkaloid used to treat depression and addiction. You won’t hear too many people say they had a fabulous time on ibogaine. It’s a grueling, perilous purge that can go on for several days. Throughout the experience, the patient is unable to eat, drink or move around. 

A research team led by UC Davis neuroscientist David Olsen is looking for a way to remove the thorns from the ibogaine experience while preserving the drug’s benefits. So far, the most promising thing they’ve found is a non-hallucinogenic ibogaine analog called tabernanthalog (TBG). Like ibogaine, TBG seems to promote neural plasticity, and it has been linked to a strong reduction in addictive and depressive behavior among rats and mice. It doesn’t carry the same health risks as ibogaine, and study results indicate that it is probably non-addictive.  

On the other hand, the rodents used in these trials needed to be given large doses of TBG for the benefits to kick in. The need for high dosages can be a sign that a medicine has a higher-than-average amount of side effects. Olson and his team are currently looking for an ibogaine analog that is effective in smaller doses. 

Medicine for the People 

Skeptics such as David Yaden, an assistant professor of psychiatry and behavioral sciences at the Johns Hopkins Center for Psychedelic and Consciousness Research, feel that the healing power of entheogens is inseparable from the epiphanic experiences that they often induce. Furthermore, Dr. Yaden recently told the New York Times that even if defused psychedelic medicines are capable of boosting mental and physical wellness, he struggles “to find rationale for withholding such a meaningful experience” from patients who are not at psychological or medical risk. 

Still, the development and distribution of trip-free psychedelics might go a long way in helping de-vilify these substances. After reaping the benefits of such medicines, some patients who were psychedelically averse might even be more willing to give the uncut versions of these alkaloids a try. As low-level consciousness brings us ever closer to self-extinction, anything that can help open minds and shift paradigms could be just what the doctor ordered. 

Damon Orion is a writer, musician, artist and teacher based in Santa Cruz, CA. Read more of his work at damonorion.com.

 

Read more: Talking to Grown-Ups about Psychedelics 

Read more: Organic vs. Synthetic 5-meO-DMT: The Psychedelic Toad Dilemma

Read more: This is a Mom on Ketamine

Similar Reads

  • How Rediscovering Awe and Wonder Benefits Mental Health
    Molly Harrison
  • Why You Should Focus on Your Joyspan
    Sara Russell
  • Tree Climbing for Adults
    Abby Grifno
  • Keeping Psychedelics Sacred
    Damon Orion

Friday newsletter

Get to first base with enlightenment